Brown Advisory’s CollPlant Biotechnologies CLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.5K Sell
10,473
-1,400
-12% -$5.39K ﹤0.01% 1439
2026
Q1
$63.6K Hold
11,873
﹤0.01% 1381
2025
Q4
$166K Hold
11,873
﹤0.01% 1348
2025
Q3
$319K Buy
11,873
+755
+7% +$18K ﹤0.01% 1184
2025
Q2
$151K Sell
11,118
-2
-0% -$41 ﹤0.01% 1315
2025
Q1
$287K Sell
11,120
-827
-7% -$29.1K ﹤0.01% 1147
2024
Q4
$430K Hold
11,947
﹤0.01% 1055
2024
Q3
$593K Hold
11,947
﹤0.01% 939
2024
Q2
$594K Sell
11,947
-7
-0.1% -$388 ﹤0.01% 908
2024
Q1
$640K Buy
11,954
+4,470
+60% +$242K ﹤0.01% 879
2023
Q4
$478K Hold
7,484
﹤0.01% 950
2023
Q3
$417K Buy
7,484
+99
+1% +$6.55K ﹤0.01% 947
2023
Q2
$603K Hold
7,385
﹤0.01% 866
2023
Q1
$518K Hold
7,385
﹤0.01% 903
2022
Q4
$617K Hold
7,385
﹤0.01% 858
2022
Q3
$502K Sell
7,385
-350
-5% -$28.4K ﹤0.01% 858
2022
Q2
$619K Hold
7,735
﹤0.01% 803
2022
Q1
$868K Buy
7,735
+1,600
+26% +$176K ﹤0.01% 742
2021
Q4
$1M Sell
6,135
-10
-0.2% -$1.78K ﹤0.01% 724
2021
Q3
$1.04M Buy
+6,145
New +$1.1M ﹤0.01% 686
2021
Q2
Sell
-5,465
Closed -$734K 1086
2021
Q1
$734K Buy
+5,465
New +$824K ﹤0.01% 777

Other funds holding CLGN

Brown Advisory's CLGN Position: Q2 2026 in Review

Brown Advisory reduced its CollPlant Biotechnologies (CLGN) stake by 12% in Q2 2026, selling an estimated $5.39K and leaving 10,473 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

Brown Advisory first reported a position in CLGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.04M in Q3 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Brown Advisory held 10,473 shares of CollPlant Biotechnologies worth $36.5K as of Q2 2026.
  • Brown Advisory sold 1,400 CollPlant Biotechnologies shares in Q2 2026, an estimated $5.39K.
  • CollPlant Biotechnologies made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #1439 holding.
  • Brown Advisory first reported a position in CollPlant Biotechnologies in Q1 2021 and has held it in 21 quarters since.
  • Brown Advisory's CollPlant Biotechnologies position peaked at $1.04M in Q3 2021.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.